Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
NT-proBNP is a blood test that measures the inactive fragment of a hormone released by the heart when its chambers are stretched or under stress. The heart’s ventricles produce a larger precursor molecule that splits into active BNP and the inactive NT-proBNP fragment, which is what this test detects. Because it is relatively stable in the bloodstream, NT-proBNP can reflect how much strain your heart is experiencing.
Doctors use this test to help evaluate symptoms such as shortness of breath, swelling, or fatigue and to assess how well your heart is handling fluid and pressure. Your result is influenced by more than the heart alone, including age, kidney function, and body size, so it is interpreted together with your history, examination, and other tests.
NT-proBNP helps your clinician judge the likelihood of heart failure when you have breathing trouble or leg swelling, and it can help distinguish heart-related causes from lung or other conditions. In people with known heart failure, it can assist with gauging severity, guiding treatment, and tracking response to therapies over time.
Levels can also change in other situations, such as kidney disease, lung conditions, irregular heart rhythms, infections, or after a heart attack. Some people, especially those with higher body weight, can have lower levels even when the heart is stressed. The test is a standard blood draw with minimal risk, and results can prompt timely care to reduce symptoms and prevent complications.
A higher NT-proBNP result usually means the heart is under more strain or pressure, but it does not by itself prove heart failure. Kidney problems, lung disease, infections, anemia, thyroid issues, or an abnormal heart rhythm can also raise the value. Your clinician will interpret your result in the context of your symptoms, examination, electrocardiogram, imaging, and other labs. Different laboratories and age groups may use different decision limits, so comparisons should be made using the same lab when possible.
If your result is higher than expected, your clinician may consider an echocardiogram, an electrocardiogram, repeat testing, medication adjustments, or checking kidney and thyroid function. If your result is lower and your symptoms are mild, heart failure is less likely, though not completely excluded. Trends over time often provide more insight than a single value. Do not start or stop medicines based on this test alone without medical advice, and seek urgent care for rapidly worsening symptoms.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Reduced kidney function slows clearance of NT-proBNP and can raise levels even when the heart is not the main problem, so results need careful interpretation.
Values tend to be higher with advancing age and can be slightly higher in females, which is considered when setting decision limits.
Higher body mass index is associated with lower circulating NT-proBNP, which can mask heart strain and make low results less definitive.
Diuretics, ACE inhibitors, ARBs, and ARNI therapy often reduce NT-proBNP as treatment takes effect; beta blockers may change levels during initiation.
Atrial fibrillation, pulmonary hypertension, acute coronary syndromes, sepsis, and severe infections can increase NT-proBNP independent of chronic heart failure.
No fasting is needed, but vigorous exercise, acute dehydration, or large fluid shifts before the blood draw can transiently affect results.
Levels may change during pregnancy and shortly after delivery; results should be interpreted with obstetric history and clinical context.
References